| Dr James Randall Ramsey, MD | |
|
1325 E Fortification St, Jackson, MS 39202-2442 | |
| (601) 354-4488 | |
| (601) 914-5181 |
| Full Name | Dr James Randall Ramsey |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 29 Years |
| Location | 1325 E Fortification St, Jackson, Mississippi |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376531582 | NPI | - | NPPES |
| 200041813 | Other | MS | MEDICARE RR |
| 00124546 | Medicaid | MS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 17187 (Mississippi) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sta Home Health And Hospice | Clinton, MS | Home health agency |
| Merit Health River Oaks | Flowood, MS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mississippi Sports Medicine And Orthopaedic Center | 4981685310 | 65 |
News Archive
Epizyme, Inc., a company leading the creation of a new class of personalized therapeutics for patients with genetically defined cancers, announced today that it has initiated a Phase 1 Study of EPZ-5676. EPZ-5676 is a novel small molecule inhibitor of DOT1L, a histone methyltransferase (HMT) that is critical to the development of a specific type of acute leukemia defined by rearrangement of the MLL gene (MLL-r leukemia).
A new study has looked into the artificial increase in the level of 'good' cholesterol and its link to the reversal of atherosclerosis in arteries.
Galderma Laboratories, L.P., has announced that the U.S. Food and Drug Administration (FDA) has approved Differin (adapalene) Gel, 0.3%, a new, higher concentration formulation of Differin (adapalene) 0.1%, a topical retinoid indicated for the treatment of acne.
Researchers have identified a molecule that may be more accurate than existing biological signposts used to predict which breast cancers will develop into advanced forms of the disease.
› Verified 9 days ago
| Entity Name | Mississippi Sports Medicine & Orthopaedic Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568415560 PECOS PAC ID: 4981685310 Enrollment ID: O20040601000238 |
News Archive
Epizyme, Inc., a company leading the creation of a new class of personalized therapeutics for patients with genetically defined cancers, announced today that it has initiated a Phase 1 Study of EPZ-5676. EPZ-5676 is a novel small molecule inhibitor of DOT1L, a histone methyltransferase (HMT) that is critical to the development of a specific type of acute leukemia defined by rearrangement of the MLL gene (MLL-r leukemia).
A new study has looked into the artificial increase in the level of 'good' cholesterol and its link to the reversal of atherosclerosis in arteries.
Galderma Laboratories, L.P., has announced that the U.S. Food and Drug Administration (FDA) has approved Differin (adapalene) Gel, 0.3%, a new, higher concentration formulation of Differin (adapalene) 0.1%, a topical retinoid indicated for the treatment of acne.
Researchers have identified a molecule that may be more accurate than existing biological signposts used to predict which breast cancers will develop into advanced forms of the disease.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr James Randall Ramsey, MD 1325 E Fortification St, Jackson, MS 39202-2442 Ph: (601) 354-4488 | Dr James Randall Ramsey, MD 1325 E Fortification St, Jackson, MS 39202-2442 Ph: (601) 354-4488 |
News Archive
Epizyme, Inc., a company leading the creation of a new class of personalized therapeutics for patients with genetically defined cancers, announced today that it has initiated a Phase 1 Study of EPZ-5676. EPZ-5676 is a novel small molecule inhibitor of DOT1L, a histone methyltransferase (HMT) that is critical to the development of a specific type of acute leukemia defined by rearrangement of the MLL gene (MLL-r leukemia).
A new study has looked into the artificial increase in the level of 'good' cholesterol and its link to the reversal of atherosclerosis in arteries.
Galderma Laboratories, L.P., has announced that the U.S. Food and Drug Administration (FDA) has approved Differin (adapalene) Gel, 0.3%, a new, higher concentration formulation of Differin (adapalene) 0.1%, a topical retinoid indicated for the treatment of acne.
Researchers have identified a molecule that may be more accurate than existing biological signposts used to predict which breast cancers will develop into advanced forms of the disease.
› Verified 9 days ago
Dr. Trevor Reed Pickering, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1325 E Fortification St, Jackson, MS 39202 Phone: 601-354-4488 Fax: 601-960-4586 | |
Latoya Braylock, Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 2500 N State St, Jackson, MS 39216 Phone: 601-984-6525 | |
Dr. Larry Daniel Field, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1325 E Fortification St, Jackson, MS 39202 Phone: 601-354-4488 Fax: 601-914-1861 | |
Dr. James William Woodall Jr., M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1325 E Fortification St, Jackson, MS 39202 Phone: 601-949-9106 Fax: 601-914-1835 | |
Kevin Francis Purcell, MD Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 2500 N State St, Jackson, MS 39216 Phone: 601-984-6525 | |
Dr. Spencer Montgomery, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2500 N State St, Jackson, MS 39216 Phone: 601-984-6525 | |
Dr. E Frazier Ward, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 2500 North State Street, Orthopaedic Surgery, Jackson, MS 39216 Phone: 601-984-6525 Fax: 601-984-5151 |